TRIMTECH Therapeutics Raises $47 Million Seed Funding To Advance Targeted Protein Degradation Portfolio
TRIMTECH Therapeutics announced that it has raised an additional $14 million in seed funding, bringing the total round to $47 million. The additional financing was...
